Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study.


We hypothesize that hydrocortisone infusion in severe community-acquired pneumonia attenuates systemic inflammation and leads to earlier resolution of pneumonia and a reduction in sepsis-related complications. In a multicenter trial, patients admitted to the Intensive Care Unit (ICU) with severe community-acquired pneumonia received protocol-guided… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.